Current and future therapies for advanced pancreatic cancer. Issue 1 (7th June 2017)

• Record Type: Journal Article
• Authors: Gupta, Rohan; Amanam, Idoroenyi; Chung, Vincent
• Other Names: Melstrom Laleh G. guestEditor.; Singh Gagandeep guestEditor.; Fong Yuman guestEditor.
• Is Part Of: Journal of surgical oncology. Volume 116:Issue 1(2017)
• Page Start: 25
• Page End: 34
• Publication Date: 2017-06-07
• Subjects: cytotoxic chemotherapy -- pancreas cancer -- vaccine therapy; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.24623
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract : Pancreatic cancer remains a deadly disease with a 5‐year survival rate of only 8%. Even after surgical resection, most patients have recurrence of their cancer. Over the last 10 years, improvements in chemotherapy regimens led to a doubling in median overall survival. Here we review the management of advanced pancreatic cancer and highlight vaccine therapy as a novel modality of treatment.